Carrie Kitko, MD

Articles by Carrie Kitko, MD

Analysis Supports Flexible Axatilimab Use in Chronic GVHD, Calls for Combination Therapy Research: Carrie Kitko, MD

July 4th 2025

Carrie Kitko, MD, explains that axatilimab maintains strong response rates in patients with chronic graft-versus-host disease (GVHD) regardless of previous treatment lines and emphasizes the need to explore combination therapies.

Post Hoc Analysis Supports Axatilimab in Heavily Pretreated Patients With Chronic GVHD: Carrie Kitko, MD

ByBrooke McCormick,Carrie Kitko, MD

July 2nd 2025

The post hoc analysis of the AGAVE-201 trial found that axatilimab demonstrated consistent response rates in patients with chronic graft-vs-host disease (GVHD), regardless of the number or type of prior therapies.

Carrie Kitko, MD

Articles by Carrie Kitko, MD

Analysis Supports Flexible Axatilimab Use in Chronic GVHD, Calls for Combination Therapy Research: Carrie Kitko, MD

Post Hoc Analysis Supports Axatilimab in Heavily Pretreated Patients With Chronic GVHD: Carrie Kitko, MD

Latest Updated Articles

Trending on AJMC

Trump Administration Flags Potential Link Between Prenatal Acetaminophen Use, Autism

Childhood Cancer Awareness Month Spotlights Barriers That Persist in Care

Medicare Beneficiaries With Near Low Income Face Highest Health Care Affordability Challenges

More Effective CKD Strategy Could Have Health, Societal Benefits

Nicotinamide Reduces New Skin Cancer Risk in Large Veteran Study